What is Tecovirimat (Intravenous Route): Uses, Dosage, Side Effects and More

Tecovirimat is an antiviral medication specifically designed to treat smallpox and monkeypox infections. This medication works by blocking the virus from spreading between cells in your body, helping your immune system fight off the infection more effectively.

The intravenous form of tecovirimat is used when patients need immediate treatment or cannot take oral medications. Your healthcare provider will determine if the IV route is the best option for your specific situation.

What is Tecovirimat?

Tecovirimat is the first FDA-approved antiviral medication specifically created to treat orthopoxvirus infections, including smallpox and monkeypox. It belongs to a class of drugs called viral protein inhibitors, which means it stops viruses from completing their life cycle in your body.

This medication was developed as part of national biodefense efforts and represents a significant breakthrough in treating these potentially serious viral infections. The intravenous formulation allows doctors to deliver the medication directly into your bloodstream when rapid treatment is needed.

Tecovirimat is also known by its brand name TPOXX, and it's considered a specialized medication that's typically reserved for confirmed or suspected orthopoxvirus infections.

What is Tecovirimat Used For?

Tecovirimat intravenous is primarily used to treat smallpox and monkeypox infections in adults and children. Your doctor might prescribe this medication if you have a confirmed infection or if you're at high risk of developing severe complications from these viruses.

The medication is most effective when started early in the course of infection, ideally within the first few days of symptom onset. However, it can still provide benefits even if treatment begins later in the illness.

In some cases, healthcare providers might use tecovirimat for other orthopoxvirus infections, such as cowpox or vaccinia virus infections, especially if these occur in immunocompromised patients or cause severe symptoms.

How Does Tecovirimat Work?

Tecovirimat works by targeting a specific protein called VP37 that orthopoxviruses need to spread from one cell to another. By blocking this protein, the medication essentially traps the virus inside infected cells, preventing it from spreading throughout your body.

Think of it like putting up roadblocks that prevent the virus from traveling to new areas of your body. This gives your immune system time to recognize and fight the infection more effectively.

This medication is considered moderately strong and highly specific to orthopoxviruses. It doesn't work against other types of viruses, which is why it's only used for confirmed or suspected smallpox and monkeypox infections.

How Should I Take Tecovirimat Intravenous?

Tecovirimat intravenous is administered only in hospital or clinical settings by trained healthcare professionals. You won't be giving this medication to yourself at home, as it requires careful monitoring and proper IV equipment.

The medication is typically given through a vein in your arm over a period of about 60 minutes. Your healthcare team will prepare the IV solution and monitor you throughout the infusion process.

You don't need to worry about taking this medication with food since it goes directly into your bloodstream. However, staying well-hydrated before and during treatment can help your body process the medication more effectively.

Your medical team will monitor your vital signs and watch for any reactions during the infusion. They'll also check your IV site regularly to ensure the medication is flowing properly.

How Long Should I Take Tecovirimat For?

The typical treatment course for tecovirimat intravenous is 14 days, though your doctor might adjust this based on your specific condition and response to treatment. Some patients may need shorter or longer treatment periods depending on the severity of their infection.

Your healthcare provider will evaluate your progress throughout treatment and may switch you to oral tecovirimat if your condition improves and you can tolerate oral medications. This transition usually happens when you're stable and no longer need intensive monitoring.

It's important to complete the full course of treatment even if you start feeling better. Stopping the medication too early might allow the virus to rebound and could lead to treatment resistance.

What Are the Side Effects of Tecovirimat?

Like all medications, tecovirimat intravenous can cause side effects, though most people tolerate it well. Understanding what to expect can help you feel more prepared and know when to alert your healthcare team.

The most common side effects you might experience include nausea, headache, and fatigue. These symptoms are usually mild and tend to improve as your body adjusts to the medication.

Here are the more frequent side effects that patients report:

• Nausea and occasionally vomiting
• Headache that may range from mild to moderate
• Fatigue or feeling more tired than usual
• Dizziness or lightheadedness
• Abdominal pain or stomach discomfort
• Diarrhea or changes in bowel movements
• Skin rash or itching at the IV site

These common side effects usually don't require treatment to stop, but your healthcare team will monitor you closely and can provide supportive care if needed.

Some patients may experience less common but more concerning side effects that require immediate medical attention. These include severe allergic reactions, unusual changes in heart rhythm, or signs of liver problems.

Rare but serious side effects include:

• Severe allergic reactions with difficulty breathing or swelling
• Irregular heartbeat or chest pain
• Yellowing of skin or eyes (signs of liver problems)
• Severe abdominal pain or persistent vomiting
• Unusual bruising or bleeding
• Severe dizziness or fainting

Your medical team is trained to recognize and manage these rare complications, so you'll be closely monitored throughout your treatment.

Who Should Not Take Tecovirimat?

Tecovirimat is generally safe for most people, but certain individuals may need special precautions or alternative treatments. Your healthcare provider will carefully review your medical history before starting this medication.

People with known allergies to tecovirimat or any of its ingredients should not receive this medication. Your doctor will ask about any previous allergic reactions to medications or other substances.

Patients with severe liver disease may need dose adjustments or alternative treatments, as the medication is processed by the liver. Your doctor will likely check your liver function before and during treatment.

Pregnant and breastfeeding women require special consideration, though the medication may still be used if the benefits outweigh the risks. Your healthcare team will discuss these considerations with you in detail.

Children can receive tecovirimat, but the dosing will be carefully calculated based on their weight and age. Pediatric patients require even closer monitoring during treatment.

Tecovirimat Brand Name

Tecovirimat is marketed under the brand name TPOXX by SIGA Technologies. This is the only FDA-approved brand of tecovirimat available in the United States.

TPOXX is available in both oral capsule and intravenous formulations, though the IV form is typically reserved for hospitalized patients or those who cannot take oral medications.

You might also hear healthcare providers refer to the medication by its generic name, tecovirimat, or by its development code ST-246, which was used during clinical trials.

Tecovirimat Alternatives

Currently, tecovirimat is the only FDA-approved antiviral medication specifically designed to treat orthopoxvirus infections like smallpox and monkeypox. However, there are other treatment approaches your doctor might consider.

Cidofovir and brincidofovir are antiviral medications that have shown some activity against orthopoxviruses, though they're not specifically approved for this use. These medications are typically reserved for severe cases or when tecovirimat isn't available.

Vaccinia immune globulin (VIG) is another treatment option that provides antibodies to help fight orthopoxvirus infections. This is often used in combination with antiviral medications for severe cases.

Supportive care remains an important part of treatment, including pain management, wound care, and maintaining proper hydration and nutrition. Your healthcare team will provide comprehensive care beyond just the antiviral medication.

Is Tecovirimat Better Than Cidofovir?

Tecovirimat is generally considered the preferred treatment for orthopoxvirus infections because it was specifically designed for these viruses and has a better safety profile than cidofovir. Cidofovir can cause significant kidney toxicity and requires careful monitoring.

While cidofovir has broader antiviral activity, tecovirimat's targeted approach means it's more effective against smallpox and monkeypox with fewer side effects. The safety difference is particularly important for patients who need extended treatment.

However, in some severe cases or when tecovirimat isn't available, cidofovir might still be used. Your healthcare provider will choose the best medication based on your specific situation, medical history, and the severity of your infection.